About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Enrolling By InvitationNCT06864598

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective treatment for acute leukaemia. The reconstitution of the recipient's immune system with donor-derived HSCT cells an...

Lead sponsor: Peking University People's Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Peking University People's Hospital

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patients proposed for allogeneic haematopoietic stem cell transplantation;
•2. Age 18\~60 years old;
•3. All enrolled patients need to sign an informed consent.

Exclusion Criteria

•1. Patients with type of transplantation as unrelated or cord blood transplantation;
•2. lack of patient compliance.

Related studies

COMPLETEDPhase 1

FMT In High-Risk Acute GVHD After ALLO HCT

NCT04139577 · Acute Graft-Versus-Host Disease (Gvhd) Grade, Hematopoietic Cell Transplantation, and more

COMPLETEDPhase 1

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

NCT02614612 · Graft-versus-host Disease (GVHD)

COMPLETEDPhase 1/2

Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)

NCT01523821 · Graft-Versus-Host Disease (GVHD) Acute on Chronic

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 7, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment100

Start dateJan 2025

Last updatedMar 7, 2025

Condition

Graft-versus-host Disease (GVHD)

Locations shown

No. 11 Xizhimen South Street, Xicheng District, Beijing, China

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions